Olanzapine for psychosis in patients with Parkinson's disease with and without dementia

被引:49
|
作者
Aarsland, D
Larsen, JP
Lim, NG
Tandberg, E
机构
[1] Rogaland Psychiat Hosp, Sect Geriatr Psychiat, N-4004 Stavanger, Norway
[2] Cent Hosp Rogaland, Sect Geriatr Psychiat, Stavanger, Norway
关键词
D O I
10.1176/jnp.11.3.392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Twenty-one patients with Parkinson's disease and psychosis were included in an open-label 8-week trial of olanzapine. Eight subjects had dementia. Six subjects (29%) discontinued treatment prematurely because of drowsiness. Delusions and hallucinations improved significantly, and 80% were rated as much or very much improved. There was no worsening of parkinsonism or cognition.
引用
收藏
页码:392 / 394
页数:3
相关论文
共 50 条
  • [1] Olanzapine for psychosis in patients with Parkinson disease with and without dementia
    Årsland, D
    Larsen, JP
    Lim, NG
    Tandberg, E
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1999, 53 (02) : 114 - 114
  • [2] Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia
    Marsh, L
    Lyketsos, C
    Reich, SG
    [J]. PSYCHOSOMATICS, 2001, 42 (06) : 477 - 481
  • [3] Characteristics of Psychosis in Parkinson's Disease without Dementia
    Barrett, Matthew
    Manning, Carol
    Shah, Binit
    Alameddin, Lama
    Stenclik, Jessica
    Joseph, Flanigan
    Harrison, Madaline
    Wooten, G.
    Sperling, Scott
    [J]. NEUROLOGY, 2016, 86
  • [4] Olanzapine for psychosis in Parkinson's disease
    Sa, DS
    Lang, AE
    [J]. NEUROLOGY, 2001, 56 (12) : 1781 - 1781
  • [5] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Wolters, EC
    Jansen, ENH
    TuynmanQua, HG
    Bergmans, PLM
    [J]. NEUROLOGY, 1996, 47 (04) : 1085 - 1087
  • [6] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Friedman, J
    [J]. NEUROLOGY, 1998, 50 (04) : 1195 - 1196
  • [7] Delirium, Psychosis and Dementia in Patients with Parkinson's Disease
    Klingelhoefer, L.
    Reichmann, H.
    [J]. AKTUELLE NEUROLOGIE, 2011, 38 (06) : 303 - 308
  • [8] TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA
    Ballard, Clive
    Mills, R.
    Williams, H.
    Corbett, A.
    Cummings, J.
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 : S2 - S2
  • [9] Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease
    Chacón, JR
    Durán, E
    Durán, JA
    Alvarez, M
    [J]. NEUROLOGIA, 2002, 17 (01): : 7 - 11
  • [10] Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease
    Breier, A
    Sutton, VK
    Feldman, PD
    Kadam, DL
    Ferchland, I
    Wright, P
    Friedman, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 438 - 445